USRE47221E1 - Tricyclic compounds - Google Patents

Tricyclic compounds Download PDF

Info

Publication number
USRE47221E1
USRE47221E1 US15/446,102 US201715446102A USRE47221E US RE47221 E1 USRE47221 E1 US RE47221E1 US 201715446102 A US201715446102 A US 201715446102A US RE47221 E USRE47221 E US RE47221E
Authority
US
United States
Prior art keywords
pyrrolo
pyrazin
ethyl
triazolo
cyclopentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US15/446,102
Inventor
Neil Wishart
Kristine E. Frank
Michael Friedman
Dawn M. George
Kent D. Stewart
Grier A. Wallace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Inc
Original Assignee
AbbVie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US26556309P priority Critical
Priority to US36411610P priority
Priority to US12/958,115 priority patent/US8426411B2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44070404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE47221(E1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AbbVie Inc filed Critical AbbVie Inc
Priority to US15/446,102 priority patent/USRE47221E1/en
Assigned to ABBOTT LABORATORIES reassignment ABBOTT LABORATORIES ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FRANK, KRISTINE E., FRIEDMAN, MICHAEL, GEORGE, DAWN M., WALLACE, GRIER A., WISHART, NEIL, STEWART, KENT D.
Assigned to ABBVIE INC. reassignment ABBVIE INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ABBOTT LABORATORIES
Application granted granted Critical
Publication of USRE47221E1 publication Critical patent/USRE47221E1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links